logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Breugelmans, Matthias
    Born in July 1986
    Individual (1 offspring)
    Officer
    icon of calendar 2022-06-29 ~ now
    OF - Director → CIF 0
  • 2
    icon of address200c, Patewood Drive, Room 4148, Greenville, Sc 29615, United States
    Corporate (1 offspring)
    Person with significant control
    icon of calendar 2022-06-29 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
Ceased 2
  • 1
    Brindley, David Alexander
    Director born in September 1989
    Individual (11 offsprings)
    Officer
    icon of calendar 2022-06-29 ~ 2024-03-26
    OF - Director → CIF 0
  • 2
    Carter, Alison Ruth, Dr
    Director born in October 1976
    Individual (5 offsprings)
    Officer
    icon of calendar 2022-06-29 ~ 2024-03-26
    OF - Director → CIF 0
parent relation
Company in focus

ELASTRIN THERAPEUTICS LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
1,363,917 GBP2024-12-31
1,119,561 GBP2023-12-31
Cash at bank and in hand
9,889 GBP2024-12-31
208,927 GBP2023-12-31
Current Assets
1,373,806 GBP2024-12-31
1,328,488 GBP2023-12-31
Net Current Assets/Liabilities
1,270,374 GBP2024-12-31
621,570 GBP2023-12-31
Total Assets Less Current Liabilities
1,270,374 GBP2024-12-31
621,570 GBP2023-12-31
Creditors
Non-current
-8,835,588 GBP2024-12-31
-7,715,700 GBP2023-12-31
Net Assets/Liabilities
-7,565,214 GBP2024-12-31
-7,094,130 GBP2023-12-31
Equity
Called up share capital
100 GBP2024-12-31
100 GBP2023-12-31
Retained earnings (accumulated losses)
-7,565,314 GBP2024-12-31
-7,094,230 GBP2023-12-31
Average Number of Employees
12024-01-01 ~ 2024-12-31
32023-01-01 ~ 2023-12-31
Trade Creditors/Trade Payables
Current
85,084 GBP2024-12-31
594,254 GBP2023-12-31

  • ELASTRIN THERAPEUTICS LIMITED
    Info
    Registered number 14203760
    icon of address2 The Old Estate Yard High Street, East Hendred, Wantage, Oxfordshire OX12 8JY
    PRIVATE LIMITED COMPANY incorporated on 2022-06-29 (3 years 6 months). The company status is Active.
    The last date of confirmation statement was made at 2025-06-28
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.